Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04052204
Title Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications

head and neck squamous cell carcinoma

prostate cancer

Therapies

Avelumab + NKTR-214

Avelumab + NKTR-214 + Talazoparib

Avelumab + Enzalutamide + NKTR-214

Age Groups: senior | adult
Covered Countries USA | ESP | BEL


No variant requirements are available.